How Has the Oral Solid Dosage Pharmaceutical Formulation Market Evolved Historically and What is its Current Size?
The oral solid dosage pharmaceutical formulation market has seen considerable growth due to a variety of factors.
• The oral solid dosage pharmaceutical formulation market has shown strong growth. It will increase from $618.34 billion in 2024 to $659.54 billion in 2025, at a compound annual growth rate (CAGR) of 6.7%.
The growth is attributed to the rising prevalence of chronic diseases, an aging population, greater healthcare access, a promotion of generic formulations, and changing consumer preferences.
What is the Forecasted Market Size and CAGR for the Oral Solid Dosage Pharmaceutical Formulation Market?
The oral solid dosage pharmaceutical formulation market is expected to maintain its strong growth trajectory in upcoming years.
• The oral solid dosage pharmaceutical formulation market is expected to grow to $842.15 billion by 2029, with a CAGR of 6.3%.
This growth is due to rising demand for personalized medicine, controlled-release formulations, biopharmaceutical focus, emerging market growth, and changes in policies and reimbursements. Trends include the adoption of personalized medicine, digital health integration, telemedicine services, preventive healthcare focus, and expanding AI use in healthcare.
What Key Factors and Trends Are Driving The Growth Oral Solid Dosage Pharmaceutical Formulation Market?
The rise in chronic illnesses is predicted to drive the expansion of the oral solid dosage pharmaceutical formulation market in the future. These conditions are long-term health issues that typically last for a minimum of three months. The increase in chronic diseases can be attributed to factors like ageing populations, inactive lifestyles, unhealthy eating habits, environmental influences, as well as advanced detection and diagnostic techniques. Oral solid dosage pharmaceutical formulations play a crucial role in managing chronic diseases and promote adherence to treatment in the long run as they are convenient, stable and allow for accurate dosing. For example, the World Health Organization, a Switzerland-based intergovernmental organization, forecasted in February 2024, that over 35 million new cancer diagnoses were expected by 2050, indicating a 77% rise compared to the projected 20 million cases in 2022. Hence, the escalating prevalence of chronic health conditions is fuelling the growth of the oral solid dosage pharmaceutical formulation market.
What Are The Market Segments In The Oral Solid Dosage Pharmaceutical Formulation Market?
The oral solid dosage pharmaceutical formulation market covered in this report is segmented –
1) By Dosage Form: Tablets, Capsules, Powders And Granules, Lozenges And Pastilles, Gummies
2) By Mechanism: Controlled-Release, Immediate-Release, Delayed-Release
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies, Hypermarkets Or Supermarkets
4) By End-User: Large-Size Companies, Medium And Small-Size Companies, Other End-Users
Subsegments:
1) By Tablets: Immediate-Release Tablets, Extended-Release Tablets, Controlled-Release Tablets, Effervescent Tablets, Chewable Tablets, Sublingual Tablets
2) By Capsules: Hard Gelatin Capsules, Soft Gel Capsules, Liquid-Filled Capsules, Delayed-Release Capsules
3) By Powders And Granules: Oral Powders (Reconstitution), Granules (Oral Suspension Or Dispersible Granules)
4) By Lozenges And Pastilles: Medicinal Lozenges, Herbal Lozenges, Sugar-Free Lozenges, Pastilles ( Throat Or Cough Relief)
5) By Gummies: Vitamin Gummies, Herbal And Nutritional Supplement Gummies, Pharmaceutical Gummies ( Pain Relief Or Sleep Aids)
Pre-Book The Oral Solid Dosage Pharmaceutical Formulation Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Reshaping The Future Of The Oral Solid Dosage Pharmaceutical Formulation Market?
Key operators in the field of oral solid dosage pharmaceutical formulation are creating groundbreaking products like liquid-filled capsules. These products potentially serve to promote drug distribution, increment bioavailability, and present suitable dosing options. The liquid-filled capsules fall into the category of oral dosages filled with gelatin shells, holding a liquid or semi-solid formulation loaded with APIs and excipients. As an illustration, Zeon Lifesciences Ltd., a pharmaceutical corporation located in India, unveiled its liquid-filled capsules in July 2023. These capsules come along with a state-of-the-art delivery system that boosts bioavailability and absorption rates, ensuring peak levels of APIs for optimal efficacy and immediate results. Zeon's capsules assist in providing exact and consistent dosages, enhancing patient satisfaction and guiding medication administration. They employ progressive technologies to improve bioavailability, enhance patient results, and secure the medication's integrity. Zeon's capsules serve as a practical, efficient, and trustworthy substitute for traditional forms of dosage, establishing a new bar for patient care and compliance in the pharmaceutical industry.
Who Are the Key Players In The Oral Solid Dosage Pharmaceutical Formulation Market?
Major companies operating in the oral solid dosage pharmaceutical formulation market are:
• Pfizer Inc.
• Johnson & Johnson
• Merck & Co. Inc.
• AbbVie Inc.
• Bayer AG
• Bristol-Myers Squibb Company
• AstraZeneca Plc.
• Novartis AG
• Hoffman-La-Roche Ltd.
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Company
• Boehringer Ingelheim GmbH
• Gilead Sciences
• Amgen Inc.
• Teva Pharmaceuticals
• Otsuka Pharmaceutical Co. Ltd.
• Astellas Pharma Inc.
• Biogen Inc.
• Lonza Group
• Catalent Inc.
• Ashland Inc.
• Piramal Pharma Solutions
• Jubilant Pharmova
• CordenPharma International
What Are The Regional Insights Into The Oral Solid Dosage Pharmaceutical Formulation Market?
North America was the largest region in the oral solid dosage pharmaceutical formulation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oral solid dosage pharmaceutical formulation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
